vs
BANK OF HAWAII CORP（BOH）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是BANK OF HAWAII CORP的1.1倍（$219.9M vs $192.3M），BANK OF HAWAII CORP净利率更高（29.9% vs -1.0%，领先30.9%），过去两年BANK OF HAWAII CORP的营收复合增速更高（10.7% vs 8.0%）
夏威夷银行是美国夏威夷州的区域性商业银行，总部位于檀香山，是夏威夷第二古老的银行，也是当地最大的本土银行，多数表决权股东均居住在州内。该行的账户数、客户规模、营业网点及ATM数量均居夏威夷金融机构首位，业务涵盖零售银行、商业银行、投资服务、资金运营四大板块。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
BOH vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$192.3M
净利率更高
BOH
高出30.9%
-1.0%
两年增速更快
BOH
近两年复合增速
8.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $192.3M | $219.9M |
| 净利润 | $57.4M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | — | 0.2% |
| 净利率 | 29.9% | -1.0% |
| 营收同比 | — | 2.0% |
| 净利润同比 | 30.6% | 92.4% |
| 每股收益（稀释后） | $1.30 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BOHOFIX
| Q1 26 | $192.3M | — | ||
| Q4 25 | $189.6M | $219.9M | ||
| Q3 25 | $182.6M | $205.6M | ||
| Q2 25 | $174.5M | $203.1M | ||
| Q1 25 | $169.9M | $193.6M | ||
| Q4 24 | $163.2M | $215.7M | ||
| Q3 24 | $162.7M | $196.6M | ||
| Q2 24 | $156.9M | $198.6M |
净利润BOHOFIX
| Q1 26 | $57.4M | — | ||
| Q4 25 | $60.9M | $-2.2M | ||
| Q3 25 | $53.3M | $-22.8M | ||
| Q2 25 | $47.6M | $-14.1M | ||
| Q1 25 | $44.0M | $-53.1M | ||
| Q4 24 | $39.2M | $-29.1M | ||
| Q3 24 | $40.4M | $-27.4M | ||
| Q2 24 | $34.1M | $-33.4M |
毛利率BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 0.2% | ||
| Q3 25 | 37.1% | -8.3% | ||
| Q2 25 | 34.6% | -7.9% | ||
| Q1 25 | 33.1% | -25.2% | ||
| Q4 24 | 31.6% | -5.3% | ||
| Q3 24 | 32.3% | -9.6% | ||
| Q2 24 | 28.9% | -12.5% |
净利率BOHOFIX
| Q1 26 | 29.9% | — | ||
| Q4 25 | 32.1% | -1.0% | ||
| Q3 25 | 29.2% | -11.1% | ||
| Q2 25 | 27.3% | -6.9% | ||
| Q1 25 | 25.9% | -27.4% | ||
| Q4 24 | 24.0% | -13.5% | ||
| Q3 24 | 24.8% | -13.9% | ||
| Q2 24 | 21.7% | -16.8% |
每股收益（稀释后）BOHOFIX
| Q1 26 | $1.30 | — | ||
| Q4 25 | $1.40 | $-0.05 | ||
| Q3 25 | $1.20 | $-0.57 | ||
| Q2 25 | $1.06 | $-0.36 | ||
| Q1 25 | $0.97 | $-1.35 | ||
| Q4 24 | $0.85 | $-0.76 | ||
| Q3 24 | $0.93 | $-0.71 | ||
| Q2 24 | $0.81 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $450.0M |
| 总资产 | $23.9B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BOHOFIX
| Q1 26 | $3.3M | — | ||
| Q4 25 | $946.5M | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | $935.2M | $58.0M | ||
| Q4 24 | $763.6M | $83.2M | ||
| Q3 24 | $1.3B | $30.1M | ||
| Q2 24 | $925.3M | $26.4M |
总债务BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | $558.2M | — | ||
| Q3 25 | $558.2M | $157.2M | ||
| Q2 25 | $558.2M | $157.0M | ||
| Q1 25 | $558.3M | $156.9M | ||
| Q4 24 | $558.3M | $157.0M | ||
| Q3 24 | $558.3M | $118.5M | ||
| Q2 24 | $560.1M | $118.0M |
股东权益BOHOFIX
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $450.0M | ||
| Q3 25 | $1.8B | $442.5M | ||
| Q2 25 | $1.7B | $458.3M | ||
| Q1 25 | $1.7B | $458.3M | ||
| Q4 24 | $1.7B | $503.1M | ||
| Q3 24 | $1.7B | $525.9M | ||
| Q2 24 | $1.6B | $546.0M |
总资产BOHOFIX
| Q1 26 | $23.9B | — | ||
| Q4 25 | $24.2B | $850.6M | ||
| Q3 25 | $24.0B | $832.6M | ||
| Q2 25 | $23.7B | $837.2M | ||
| Q1 25 | $23.9B | $823.1M | ||
| Q4 24 | $23.6B | $893.3M | ||
| Q3 24 | $23.8B | $867.9M | ||
| Q2 24 | $23.3B | $882.0M |
负债/权益比BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.31× | 0.36× | ||
| Q2 25 | 0.32× | 0.34× | ||
| Q1 25 | 0.33× | 0.34× | ||
| Q4 24 | 0.33× | 0.31× | ||
| Q3 24 | 0.34× | 0.23× | ||
| Q2 24 | 0.35× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | $218.3M | $27.7M | ||
| Q3 25 | $38.5M | $12.4M | ||
| Q2 25 | $81.7M | $11.6M | ||
| Q1 25 | $18.3M | $-18.4M | ||
| Q4 24 | $170.9M | $23.7M | ||
| Q3 24 | $-20.3M | $11.7M | ||
| Q2 24 | $45.7M | $9.0M |
自由现金流BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | $184.3M | $16.8M | ||
| Q3 25 | $29.8M | $2.5M | ||
| Q2 25 | $72.6M | $4.5M | ||
| Q1 25 | $10.2M | $-25.1M | ||
| Q4 24 | $161.3M | $15.2M | ||
| Q3 24 | $-25.0M | $6.3M | ||
| Q2 24 | $40.7M | $-360.0K |
自由现金流率BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 97.2% | 7.6% | ||
| Q3 25 | 16.3% | 1.2% | ||
| Q2 25 | 41.6% | 2.2% | ||
| Q1 25 | 6.0% | -13.0% | ||
| Q4 24 | 98.8% | 7.0% | ||
| Q3 24 | -15.3% | 3.2% | ||
| Q2 24 | 26.0% | -0.2% |
资本支出强度BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 18.0% | 4.9% | ||
| Q3 25 | 4.7% | 4.8% | ||
| Q2 25 | 5.2% | 3.5% | ||
| Q1 25 | 4.8% | 3.5% | ||
| Q4 24 | 5.9% | 4.0% | ||
| Q3 24 | 2.8% | 2.7% | ||
| Q2 24 | 3.2% | 4.7% |
现金转化率BOHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 3.58× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | -0.50× | — | ||
| Q2 24 | 1.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BOH
| Net Interest Income | $151.0M | 79% |
| Noninterest Income | $41.3M | 21% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
